Circulating tumor DNA to detect minimal residual disease, response to adjuvant therapy and identify patients at high risk of recurrence

Tarazona N, Henriksen TV, Carbonell-Asins JA, et al. Oral presentation at: American Society of Clinical Oncologist; May 29-31, 2020; Virtual Meeting. Abstract 4009